Gene · 4973
Papers4,129
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,129
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell transcriptome analysis identifies MIF as a novel tumor-associated neutrophil marker for pancreatic ductal adenocarcinoma. | NPJ Precis Oncol | 2025 | 40835726 | PubTator, text mining | PubMed |
| Molecular Docking and Functional Analyses Reveal the Chondroprotective and Anti-Inflammatory Potential of Statins in Osteoarthritis. | J Cell Mol Med | 2025 | 40830819 | PubTator, text mining | PubMed |
| Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology. | NPJ Digit Med | 2025 | 40819002 | PubTator, text mining | PubMed |
| Hinokiflavone alleviates high-fat diet-induced erectile dysfunction via the EGFR/PI3K/Akt/eNOS signaling pathway. | Sex Med | 2025 | 40808867 | PubTator, text mining | PubMed |
| Genetic overlap between sarcoidosis and lung cancer: a combined in silico and in vitro approach. | Hereditas | 2025 | 40797277 | PubTator, text mining | PubMed |
| Protective Effect of N-Acetylcysteine (NAC) on oxLDL-Induced Endothelial Dysfunction. | J Microbiol Biotechnol | 2025 | 40774821 | PubTator, text mining | PubMed |
| Anti-centromere antibody positivity with coexisting idiopathic portal hypertension and primary biliary cholangitis progressing to limited cutaneous systemic sclerosis: a case report. | J Med Case Rep | 2025 | 40764937 | PubTator, text mining | PubMed |
| Tricuspid Aortic Valve Regurgitation Associates With Ascending Aortic Aneurysm Through Endothelial Activation and Lipoprotein Infiltration. | Arterioscler Thromb Vasc Biol | 2025 | 40740135 | PubTator, text mining | PubMed |
| The Association Between Subclinical Atherosclerosis Serum Markers and Oxidative DNA Damage in Normoglycemic Normotolerant Offspring of Diabetic Parents. | J Diabetes | 2025 | 40739796 | PubTator, text mining | PubMed |
| Impact of biomarkers on carotid artery disease and stroke. | Sci Rep | 2025 | 40738952 | PubTator, text mining | PubMed |
| Serum asprosin, ox-LDL, and LOX-1 levels in patients with hypertension and their association with cardiovascular risk. | Biomark Med | 2025 | 40734353 | PubTator, text mining | PubMed |
| SIRT4 Regulated by a Mechanosensor, PIEZO1 Shows a Protective Function to Suppress Ox-LDL Uptake in Endothelial Cells. | Tissue Eng Regen Med | 2025 | 40643822 | PubTator, text mining | PubMed |
| PPP2CB aggravates atherosclerosis-related dyslipidemia via LOX-1/MAPK/ERK signaling pathway. | Lipids Health Dis | 2025 | 40611318 | PubTator, text mining | PubMed |
| Modified Lipid Particle Recognition: A Link Between Atherosclerosis and Cancer? | Biology (Basel) | 2025 | 40563926 | PubTator, text mining | PubMed |
| Causal role of endothelial dysfunction in ischemic stroke and its subtypes: A two-stage analysis. | SLAS Technol | 2025 | 40543716 | PubTator, text mining | PubMed |
| Oxidized LDL enhances Gq signaling and aldosterone production by angiotensin II via the AT1-LOX-1 receptor complex in adrenal cells. | Hypertens Res | 2025 | 40533529 | PubTator, text mining | PubMed |
| Mutation within the transmembrane domain of oxidized low-density lipoprotein receptor 1 influences oxidized low-density lipoprotein-induced signal transduction. | Innate Immun | 2025 | 40518921 | PubTator, text mining | PubMed |
| Glutathione as a Therapeutic Agent for OxLDL-Induced Endothelial Dysfunction and Atherosclerosis Prevention. | Cell Biol Int | 2025 | 40511641 | PubTator, text mining | PubMed |
| Protective effect of Allium hookeri water extract and its main compound, Cycloalliin, on foam cell formation in THP-1-derived macrophages. | Food Nutr Res | 2025 | 40475061 | PubTator, text mining | PubMed |
| Correspondence: Exploring the relationship between serum LOX-1, Ox-LDL, and generalized anxiety disorder. | J Affect Disord | 2025 | 40398615 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4973/papers?page=7